Physician profile
Michael Edmond Franks
NPI 1508839242
$15,545.39
in general payments reported to CMS, 2019-2025
60 companies · $4,596 in 2025
The $4,596 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,424 · 2020: $979 · 2021: $1,804 · 2022: $2,346 · 2023: $2,330 · 2024: $2,066 · 2025: $4,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,593 · Travel and Lodging: $1,391 · Education: $8.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,592.78 |
| Travel and Lodging | $1,390.93 |
| Education | $8.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,915.27 | 2025 | Nanoknife |
| Dendreon Pharmaceuticals LLC | $1,608.65 | 2019-2024 | Provenge |
| Pfizer INC. | $1,118.61 | 2019-2025 | |
| Astellas Pharma US INC | $1,097.01 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $962.05 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $898.34 | 2019-2025 | |
| Abbvie INC. | $795.62 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $663.18 | 2019-2024 | Xiaflex, Aveed, Edex |
| Sumitomo Pharma America, INC. | $585.66 | 2023-2025 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $504.19 | 2019-2025 | Posluma |
| Abiomed | $454.49 | 2025 | |
| Endo USA, INC. | $401.10 | 2024-2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $387.99 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Amgen INC. | $366.45 | 2019-2023 | Prolia |
| Urogen Pharma, INC. | $349.13 | 2021-2025 | Jelmyto |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $322.14 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $283.61 | 2022-2025 | Pylarify |
| Boston Scientific Corporation | $282.33 | 2019-2025 | Ams 700, Rezum Generator, Lumenis Pulse 120h |
| Neotract INC. | $236.33 | 2019-2020 | |
| Myovant Sciences INC. | $219.08 | 2021-2022 | |
| Accord Healthcare, INC. | $191.98 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $172.54 | 2021-2024 | Lynparza |
| Merck Sharp & Dohme LLC | $170.79 | 2020-2024 | Keytruda, Lynparza, Welireg |
| Profound Medical Corp. | $110.37 | 2025 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $104.79 | 2019-2025 | Adstiladrin |
| Urovant Sciences INC | $89.41 | 2022 | |
| Teleflex LLC | $83.25 | 2020-2023 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $82.08 | 2023 | Surestep Foley Tray System Bardex I.C. Complete Care Foley Catheter, Bard Urinary Drainage Bag |
| Tempus Ai, INC | $80.48 | 2024 | Xt Cdx |
| Tolmar Pharmaceuticals, INC. | $73.38 | 2020-2022 | |
| Halozyme INC | $72.12 | 2023 | |
| Ambu INC. | $64.27 | 2022-2024 | |
| Foundation Medicine, INC. | $63.92 | 2019-2022 | |
| Olympus America INC. | $54.52 | 2025 | Itind System |
| Photocure INC | $51.84 | 2019-2021 | |
| Mission Pharmacal Company | $51.01 | 2019-2020 | |
| Davol INC. | $47.38 | 2023 | Arista Ah Flexitip |
| Travere Therapeutics, INC. | $47.22 | 2020-2022 | |
| Inspire Medical Systems, INC. | $47.02 | 2025 | Inspire |
| Procept Biorobotics Corporation | $46.42 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Allergan, INC. | $39.54 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $39.04 | 2023 | Yonsa |
| Genzyme Corporation | $30.19 | 2019 | |
| Tolmar, INC. | $30.00 | 2024 | |
| Abc Home Medical Supply, INC. | $29.63 | 2025 | |
| Rochester Medical Corporation | $28.34 | 2020 | |
| Myriad Genetic Laboratories, INC. | $25.34 | 2021 | |
| Clovis Oncology, INC. | $24.27 | 2020 | |
| Clarus Therapeutics INC. | $22.60 | 2021 | |
| Cardinal Health 414 LLC | $18.89 | 2022 | |
| Telix Pharmaceuticals | $17.70 | 2022 | |
| Verity Pharmaceuticals INC. | $16.59 | 2023 | Trelstar |
| Ethicon US, LLC | $16.43 | 2021 | |
| Immunitybio, INC. | $15.90 | 2024 | |
| Metuchen Pharmaceuticals | $13.31 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Franks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.